Medical News

RSS

New report provides snapshot of Canada's cancer system

A comprehensive report released today by the Canadian Partnership Against Cancer provides a snapshot of how Canada's cancer system is performing in key areas from prevention through to patient experience and outcomes.

17 Dec 2012

Alexian Brothers Health System implements online service to reduce wait times in ERs

Hospitals across the country are investigating ways to improve their patients' experience through decreasing waiting times in emergency rooms and in immediate care settings.

17 Dec 2012

SeeChange Health Insurance to expand product offerings with Liazon

SeeChange Health Insurance, the leader in value-based benefit design solutions for small and midsized employers and the fastest-growing health plan in California and Colorado, is partnering with Liazon Corporation to expand its product offerings.

17 Dec 2012

NeoGenomics launches FISH assay for surveillance of patients with Barrett's Esophagus

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today it has validated and launched a laboratory developed Fluorescent in Situ Hybridization assay for the surveillance of patients with Barrett's Esophagus.

17 Dec 2012

Survey shows health care costs projected to increase at slower pace

Projected cost increases for all types of medical plans are anticipated to be down by between 0.2 and 0.6 percent through the first half of 2013, according to a survey by Buck Consultants, A Xerox Company.

17 Dec 2012

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).

17 Dec 2012

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Allakos Inc. announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. Peter Moldt , PhD., Partner at Novo Ventures, Robert Alexander , PhD., Director at Alta Partners and John McKearn PhD., Managing Director at RiverVest Venture Partners, will join the Board of Directors.

17 Dec 2012

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

ProMining Therapeutics, Ltd. today announced a new collaboration with Roche in the field of type 2 diabetes mellitus.

17 Dec 2012

Naurex announces completion of $38M Series B financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $38 million Series B financing led by new investor Baxter Ventures.

17 Dec 2012

New research reveals music's health benefits

Music has been incorporated into medical practice since before the ancient Greeks. However, though practitioners have been convinced of music's health benefits for thousands of years, there had been little peer-reviewed research to back them up. But recent studies are providing an empirical backbone for the anecdotal evidence.

17 Dec 2012

UMCG enrolls and treats first patients in RENEW pivotal trial to evaluate RePneu LVRC

PneumRx, Inc., a leader in interventional pulmonology, announced today that University Medical Center Groningen has enrolled and treated the first patients in the FDA-approved RENEW pivotal trial to evaluate the RePneu Lung Volume Reduction Coil.

17 Dec 2012

First Edition: December 17, 2012

Today's headlines include weekend updates regarding the fiscal cliff negotiations as well as news regarding states' decisions on health exchanges.

17 Dec 2012

Range of epigenetic immunoassays from VolitionRx now available for research use

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces the launch of NuQ, its range of research use only epigenetic immunoassays, to be available for sale at www.nucleosomics.com.

17 Dec 2012

Study reveals how BRCA1 enzymatic activity may stop cancer cell growth

A new study by Georgetown University Medical Center researchers reveals how a well-known tumor suppressor gene may be functioning to stop cancer cell growth.

17 Dec 2012

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.

17 Dec 2012

GTx achieves enrollment goal for pivotal Phase III clinical studies of enobosarm

GTx, Inc. today announced that it has attained its enrollment goal for both of its pivotal Phase III clinical studies of enobosarm to prevent and treat muscle wasting in non-small cell lung cancer patients.

17 Dec 2012

Dyslipidaemia: an interview with Prof. Peter Kokkinos

Dyslipidemia is defined as abnormal levels of blood lipids (fats) and cholesterol. The most common dyslipidaemias are high blood cholesterol (Total Cholesterol) and triglyceride levels, high levels of low-density lipoprotein (LDL) cholesterol (‘bad’ cholesterol) and low levels of high-density lipoprotein (HDL) cholesterol (‘good’ cholesterol).

17 Dec 2012

Loading up on snack foods may increase cancer risk in individuals with Lynch syndrome

A new analysis has found that loading up on snack foods may increase cancer risk in individuals with an inborn susceptibility to colorectal and other cancers. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that an eating pattern low in snack foods could help these individuals-who have a condition called Lynch syndrome-lower their risk.

17 Dec 2012

New technique could help develop more-specific, cell-based immune therapies for cancer

A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development of more-specific, cell-based immune therapies for cancer.

17 Dec 2012

Increased life expectancy not benefitting everybody equally: U of T

Global lifespans have risen dramatically in the past 40 years, but the increased life expectancy is not benefitting everybody equally, say University of Toronto researchers. In particular, adult males from low- and middle-income countries are losing ground.

17 Dec 2012

Medical News

New report provides snapshot of Canada's cancer system

Alexian Brothers Health System implements online service to reduce wait times in ERs

SeeChange Health Insurance to expand product offerings with Liazon

NeoGenomics launches FISH assay for surveillance of patients with Barrett's Esophagus

Survey shows health care costs projected to increase at slower pace

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Allakos closes $32M Series A financing to develop antibody-based therapeutics

ProMining Therapeutics, Roche to develop small molecule therapeutics for type 2 diabetes mellitus

Naurex announces completion of $38M Series B financing

New research reveals music's health benefits

UMCG enrolls and treats first patients in RENEW pivotal trial to evaluate RePneu LVRC

First Edition: December 17, 2012

Range of epigenetic immunoassays from VolitionRx now available for research use

Study reveals how BRCA1 enzymatic activity may stop cancer cell growth

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

GTx achieves enrollment goal for pivotal Phase III clinical studies of enobosarm

Dyslipidaemia: an interview with Prof. Peter Kokkinos

Loading up on snack foods may increase cancer risk in individuals with Lynch syndrome

New technique could help develop more-specific, cell-based immune therapies for cancer

Increased life expectancy not benefitting everybody equally: U of T

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News